Brief: Gland Pharma Says FDA Concluded Inspection At Dundigal Facility
24/08/2023 06:54
Aug 24 (Reuters) - Gland Pharma Ltd GLAD.NS :
* CONCLUSION OF US FDA INSPECTION AT DUNDIGAL FACILITY OF
THE
COMPANY
* RECEIVED ESTABLISHMENT INSPECTION REPORT FROM US FDA
INDICATING
CLOSURE OF INSPECTION
Source text for Eikon: ID:nBSE7YZ5lB
Further company coverage: GLAD.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gland Pharma
See all newsIndia Stocks: Indian shares open higher as Fed-hike fears, oil prices ease; financials lead
India Stocks: Indian shares poised to rebound as Fed-hike fears, oil prices ease
Brief: Gland Pharma Approves $21 Million Investment In Gland Pharma Usa
Brief: Fosun Pharma Says Unit Sold Gland Pharma Shares for $294 Mln
India's Gland Pharma gains on successful completion of US FDA probe at Visakhapatnam plant